On 12 – 13 February 2025, at the HL7 Europe Working Group Meeting and EU-a-thon, HL7 Europe led the “Common Cancer Model Track”. The aim of the track was to use the experience achieved in European project, such as PanCareSurPass and national initiatives, to define a minimal, extensible, non-exhaustive European cancer data model that is:
- agnostic to the type of cancer,
- usable across different use cases,
- leverages the experiences of the European projects working with primary and secondary usage,
- takes into account the availability and usability of reliable data in electronic health record (EHR) systems, and
- allows its HL7 FHIR representation in the form of an HL7 FHIR Implementation Guide.
The event went beyond expectations – with more than 30 participants from 11 EU countries, the track created the first draft of a European Common Cancer Conceptual Model of the cancer journey on a timeline.
As next steps, HL7 Europe will continue the activity conceptual model, and will start on the European Common Cancer Logical Model and on the HL7 Europe Cancer Common FHIR Implementation Guide. This work will be presented at the next HL7 International Working Group Meeting that will be hosted in Madrid in May 2025, allowing opportunities for discussion with the international community.
Please visit the HL7 Europe LinkedIn page to be updated on the next events on the Common Cancer Model and join the initiative!
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 899999. The material presented and views expressed here are the responsibilities of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.